09 February 2024 | Friday | News
Image Source | Public Domain
As the demand for imaging services grows, advancements in technology enable a broader range of services to be provided in ambulatory settings, which can help alleviate the burden on acute care hospitals. Innovative care models and emerging technologies in outpatient imaging are vital to boosting operational efficiency and expanding access, helping ensure top-tier patient care. MedQuest’s model of joint ventures with health systems, coupled with GE HealthCare’s innovative technologies, will help deploy emerging imaging solutions, including solutions to support Theranostics, into the ambulatory setting.
MedQuest CEO Jason Howard shared, “Our commitment to customer-centric care is at the center of everything we do. Building upon our more than 25-year history as a leader in outpatient imaging, our partnership with GE HealthCare will position us at the forefront of innovative care delivery and product line development, enhancing the level of care for our patients and health system partners.”
MedQuest will continue to broaden their ability to provide high-performing care in the outpatient imaging space with the addition of AI-enabled digital capabilities from GE HealthCare, including AIR Recon DL, AIR Touch Technology, Imaging Protocol Manager, Smart Subscription and Digital tools with Imaging 360. These innovative capabilities will help enable clinicians to provide improved outcomes for patients and deliver personalized, precise patient care, while improving radiology workflows and helping ease workloads for care teams.
“GE HealthCare is excited to provide advanced technologies and digital tools to enable clinicians to make faster, more informed decisions through intelligent data and smart devices to help improve patient outcomes,” said Jason Schneck, President, U.S. & Canada Imaging, GE HealthCare. “We are relentlessly focused on improving the healthcare experience for patients everywhere.”
This collaboration will assist hospitals and healthcare systems in further expanding their reach into the communities they serve and their impact on delivering care for their patients.
© 2024 Biopharma Boardroom. All Rights Reserved.